“…The studies on biomarkers of inflammation were mostly cross-sectional. Endpoints consisted of a long list of biomarkers related to oxidative stress Yuan et al, 2017), inflammation (Kumar, Lind, Salihovic, van Bavel, Ekdahl, et al, 2014;Schaebel et al, 2017;Yuan et al, 2017;Zota, Geller, et al, 2018), immune system (Kumar, Lind, Salihovic, van Bavel, Ekdahl, et al, 2014) and non-alcoholic fatty liver disease (Rantakokko et al, 2015, Midya et al, 2022, as full listed in Table 30 and Appendix D. The large variation in biomarkers between studies and mostly cross-sectional study designs preclude an integrative assessment of the evidence at this stage. In the only prospective study in this group, liver injury and hepatocellular apoptosis was assessed in relation to prenatal BDE-47 and -153 levels by Midya et al (2022) using a collaborative network of six ongoing, population-based prospective birth cohort studies from six European countries (France, Greece, Lithuania, Norway, Spain and the UK; HELIX study, n = 1108).…”